-+ 0.00%
-+ 0.00%
-+ 0.00%

ATYR PHARMA INC - PRIMARY ENDPOINT WILL BE CHANGE IN FVC AT WEEK 48; KEY SECONDARY ENDPOINT WILL BE CHANGE FROM BASELINE IN KSQ-LUNG SCORE

Reuters·05/11/2026 20:01:00

Please log in to view news